Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Andrew Mcfarland (NPI 1538427471)

Field	Value
Entity Type	Individual
Organization	Andrew Mcfarland
Address	190 Campus Blvd Ste 320
City	Winchester
State	VA
ZIP	22601
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	April 29, 2012

Payer Source	Total Paid
Medicare	$3.1M
Medicaid	$0

Key Findings

This provider is a retina-focused ophthalmology specialist by taxonomy and billing mix: the top revenue codes are anti-VEGF intravitreal drug injections (J0178, J2777, J2778) and related retina procedures (67028, 92134), indicating the practice primarily delivers intravitreal pharmacologic therapy and advanced retinal imaging rather than general ophthalmic primary care or high-volume surgical retina. The presence of high-volume drug codes and retina imaging supports a practice model centered on medical retina management (wet AMD, DME, other neovascular conditions).

Medicare revenue is concentrated in a very small set of services: the precomputed top 3 Medicare codes account for 87.5% of this provider's total Medicare revenue, and individually J0178 ($1.4M, 44.4% of Medicare revenue) and J2777 ($1.1M, 36.5% of Medicare revenue) dominate receipts. This concentration implies financial dependence on recurring intravitreal injections (aflibercept and faricimab), with comparatively limited revenue contribution from evaluation-and-management or surgical codes.

The provider’s Medicare-versus-Medicaid payer mix is effectively single-payer: lifetime Medicare revenue is $3.1M while there is no Medicaid billing on file. This suggests the provider either does not participate in Medicaid, sees few Medicaid patients, or bills under another taxonomy/group for Medicaid — but in any case Medicare represents essentially the entire reported public-payer activity.

Competitive standing for the highest-revenue drug codes is mixed: for J0178 the provider ranks #542 of 3204 (83th percentile) and for J2777 ranks #178 of 2039 (91th percentile), which indicates above-typical national volumes for these intravitreal agents but not market dominance. These percentiles describe a practitioner with consistently higher-than-average throughput for anti-VEGF treatments relative to most peers, particularly notable for faricimab (J2777).

There is an important statistical outlier in diagnostic imaging: 92134 (retinal imaging/interpretation) shows 2.5K claims and ranks #666 of 26868 providers nationally (98th percentile), labeled an "extreme outlier". This exceptionally high volume of retinal imaging relative to peers suggests substantial use of OCT or similar posterior-segment imaging as part of the clinical workflow, reinforcing the medical-retina, injection-focused practice pattern.

Other service lines and office E/M activity are modest: CPTs such as 92014 (449 claims, $32.3K) and E/M codes 99213/99214 have relatively small shares of total Medicare revenue (around 1.0% each), indicating that routine office visits and general ophthalmology exams are secondary to the injection-and-imaging revenue stream. Surgical retina codes (e.g., 67036) appear but account for a minimal share, so operative intervention is a far smaller component of reported Medicare revenue.

Tenure in the Medicare enrollment system is long: the NPI was enumerated on 2012-04-29 (about 14 years ago), indicating sustained participation and an established billing history in Medicare, which supports interpreting the observed high imaging and injection volumes as an ongoing, stable practice pattern rather than a short-term fluctuation.

Procedure-level ranks for other intravitreal agents and implants are generally around typical ranges: J7312 (dexamethasone implant) ranks #338 of 492 (29th percentile) and J9035 (bevacizumab) ranks #648 of 1852 (65th percentile), signaling selective use of alternative pharmacologic options but clear preference and volume concentration on aflibercept and faricimab. These patterns suggest formulary or clinical preference rather than broad, even utilization across all available intravitreal therapies.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,990	$680	$1.4M
J2777	Injection, faricimab‑svoa, 0.1 mg	38,460	$30	$1.1M
J2778	Injection, ranibizumab, 0.1 mg	1,130	$180	$204.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,620	$90	$152.5K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,510	$30	$70.1K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	450	$70	$32.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	450	$70	$30.1K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	190	$160	$29.9K
J9035	Injection, bevacizumab, 10 mg	210	$50	$11.3K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	100	$110	$10.8K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

Andrew Mcfarland — 1 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	30	80	1,400	$690	$1.1M
J2777	6	60	13,200	$30	$517.1K
J2778	11	40	560	$180	$171.5K
67028	27	90	1,000	$90	$107.1K
J7312	14	20	240	$160	$42.5K
92014	217	870	170	$80	$32.8K
99214	7,708	12,890	140	$80	$21K
J9035	24	60	170	$50	$19.9K
67036	9	20	20	$940	$19.8K
99213	1,008	12,440	90	$60	$10K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Andrew Mcfarland, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Daniel Bennett	NC	Retina Specialist (Ophthalmology) Physician	$3M	$0
Daniel Kasuga	TX	Retina Specialist (Ophthalmology) Physician	$2.9M	$0
Eric Steuer	VA	Retina Specialist (Ophthalmology) Physician	$2.7M	$0
Jason Ruggiero	VA	Retina Specialist (Ophthalmology) Physician	$2.5M	$0
Edgar Ready	AL	Retina Specialist (Ophthalmology) Physician	$2.5M	$0
Wasim Samara	TX	Ophthalmology Physician	$2.3M	$0
Kevin Wells	TX	Ophthalmology Physician	$2.1M	$0
Charles Clark	TX	Ophthalmology Physician	$2.1M	$0
Eric Zavaleta	TX	Ophthalmology Physician	$1.9M	$0
Shaina Rubino Loverde	VA	Retina Specialist (Ophthalmology) Physician	$1.8M	$0

Nearby Providers

Other providers in the same ZIP code as Andrew Mcfarland, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Grafton School, Inc.	VA	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$92M
Winchester Medical Center	VA	General Acute Care Hospital	$0	$69.9M
Grafton School Inc	VA	Psychiatric Residential Treatment Facility	$0	$33M
Shenandoah Valley Community Residences, Inc.	VA	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$17.4M
Compassionate Home Care	VA	In Home Supportive Care Agency	$0	$14.5M
Nova Family Services, Inc.	VA	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$13.5M
Uncle Sam Transportation LLC	VA	Taxi	$0	$12M
National Counseling Group, Inc	VA	Mental Health Counselor	$0	$11.2M
Pediatrix Medical Group PC	VA	Neonatal-Perinatal Medicine Physician	$0	$10.8M
Winchester Medical Center	VA	Obstetrics & Gynecology Physician	$0	$10M

Andrew Mcfarland — Billing Profile & Reimbursement Data

Sign up for Andrew Mcfarland — Billing Profile & Reimbursement Data policy alerts

Andrew Mcfarland — Billing Profile & Reimbursement Data

Sign up for Andrew Mcfarland — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References